You are here

  • Home
  • Archive
  • Volume 6, Issue 9
  • Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)

Citation Tools

Article menu

Download PDFPDF

XML
Intensive care
Protocol
Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Peters E, Mehta RL, Murray PT, et al
Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)
BMJ Open 2016;6:e012371. doi: 10.1136/bmjopen-2016-012371